Skip to main content
Equibles
CRDL logo

CRDL · Cardiol Therapeutics Inc.

Track CRDL — free

Use CRDL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.94 -0.12 (-5.83%) At close · Aug 28
Rebalance outlook locked
Market Cap
$226.64M
Shares
116.82M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-08-11 Cardiol Therapeutics Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference Conference
2026-07-16 Cardiol Therapeutics Fireside Chat at B. Riley Securities Mind, Muscle, & Vision Summit Event
2026-07-16 B. Riley Securities Mind, Muscle & Vision Summit Event
2026-06-30 Canaccord Genuity's KOL Event Featuring Paul Cremer, M.D, the MAVERIC Phase III trial Principal Investigator and MAVERIC Program Steering Committee Member Event
2026-06-24 2026 Annual General Meeting of Shareholders Shareholder meeting
2026-05-19 Cardiol Therapeutics (CRDL) Fireside Chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ Conference
2026-05-19 Cardiol Therapeutics ($CRDL): A New Approach to Treating Inflammation in Heart Disease Event
2026-04-28 Ellis Martin: Cardiol Therapeutics (CRDL) CEO David Elsley on Breakthrough Heart Disease Treatment Event
2026-04-16 The Deep Dive Interview: Conversation with David Elsley, President and CEO of Cardiol Therapeutics (CRDL) Event
2026-04-14 Barchart Interview: Cardiol Therapeutics: The Heart Drug Story Retail Investors Aren't Talking About...Yet! Event
2026-03-04 TD Cowen 46th Annual Health Care Conference Conference
2025-12-11 Discussion with David Elsley, President & CEO on the SmithWeekly Podcast Event
2025-12-01 Cardiol Therapeutics Presentation of Phase II ARCHER Trial Results Presentation
2025-10-26 Nasdaq Amplify Spotlight – Cardiol Therapeutics: Featuring President & CEO, David Elsley Event
2025-09-09 H.C. Wainwright 27th Annual Global Investment Conference Conference
2025-09-02 The KE Report Podcast: Cardiol Therapeutics – Advancing Breakthrough Therapies for Inflammatory Heart Disease Event
2025-08-12 The Deep Dive Interview: David Elsley, President & CEO of Cardiol Therapeutics Event
2025-08-12 Canaccord Genuity's 45th Annual Growth Conference Conference
2025-05-28 2025 Annual General Meeting of Shareholders Shareholder meeting
2025-04-18 The Deep Dive Interview: David Elsley, President & CEO of Cardiol Therapeutics Event
2025-03-18 37th Annual ROTH Conference Conference
2025-03-05 TD Cowen 45th Annual Health Care Conference Conference
2025-02-12 Oppenheimer's 35th Annual Healthcare Life Sciences Conference Conference
2024-11-18 American Heart Association Scientific Sessions 2024 – MAvERIC Phase II full clinical data will be reported in an oral presentation Presentation
2024-09-12 David Elsley on Making Money with Charles Payne – Inside the production pipeline for new drugs to combat heart failure Event

Source: https://www.cardiolrx.com/investor-relations/

Key facts CIK 1702123 CUSIP 14161Y200 13F (30d) 42 filings 41 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)